Matches in Wikidata for { <http://www.wikidata.org/entity/Q61651011> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q61651011 description "article scientifique (publié 2006)" @default.
- Q61651011 description "artikull shkencor i botuar më 01 janar 2006" @default.
- Q61651011 description "artículu científicu espublizáu en xineru de 2006" @default.
- Q61651011 description "im Jahr 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61651011 description "scientific article published on 01 January 2006" @default.
- Q61651011 description "wetenschappelijk artikel" @default.
- Q61651011 description "наукова стаття, опублікована в січні 2006" @default.
- Q61651011 name "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 name "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 name "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 type Item @default.
- Q61651011 label "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 label "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 label "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 prefLabel "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 prefLabel "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 prefLabel "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 P1433 Q61651011-D29CF341-2B8F-491D-A77B-6CC91075ACF2 @default.
- Q61651011 P1476 Q61651011-9EE117B7-3CC6-4BC0-9DE3-73B0E8ADC69F @default.
- Q61651011 P2093 Q61651011-15F424A8-357C-450B-B09B-101BC46DC041 @default.
- Q61651011 P2093 Q61651011-173786E2-71F7-4533-A2B3-D1B0CD4A10A2 @default.
- Q61651011 P2093 Q61651011-582B45FA-0E27-4417-9E12-ED12C6ED06F6 @default.
- Q61651011 P2093 Q61651011-6E220246-EF38-4F97-AD74-1F4BB88F1C16 @default.
- Q61651011 P2093 Q61651011-80381666-0794-4533-9907-9F8A0E641831 @default.
- Q61651011 P2093 Q61651011-976F627B-0E81-4955-A11A-1817C88E016D @default.
- Q61651011 P2093 Q61651011-C9F1D228-2706-46DF-8EB1-345C23B9BD60 @default.
- Q61651011 P2093 Q61651011-DEC67EE4-E599-42ED-86D1-347008EFEC3A @default.
- Q61651011 P2093 Q61651011-F6C26623-D736-48BB-A0FE-40A37CB403D9 @default.
- Q61651011 P2093 Q61651011-F8C74774-8AAD-4E69-8EE0-7F392A55DDCA @default.
- Q61651011 P304 Q61651011-3436C586-4160-469F-8F8F-C463194942FA @default.
- Q61651011 P31 Q61651011-1171A90F-5FFF-4DB0-962E-2DBA2AA36837 @default.
- Q61651011 P356 Q61651011-6B28F43E-C9D4-406A-904E-0B05C6FA7FC1 @default.
- Q61651011 P407 Q61651011-408A83B7-E05B-403C-80A6-A75705237034 @default.
- Q61651011 P433 Q61651011-181E3A13-8DC1-42A1-B4D1-A078ABAA40D0 @default.
- Q61651011 P478 Q61651011-99ABF533-77A4-470D-B7AF-26FF0D2E6929 @default.
- Q61651011 P50 Q61651011-2EFD6153-2330-4DBE-9959-5F961F744E1D @default.
- Q61651011 P577 Q61651011-7AEFEE27-B26F-4491-BA2C-7EFF81846D69 @default.
- Q61651011 P698 Q61651011-9B588CE5-0512-4B08-B8CF-290288F0767C @default.
- Q61651011 P921 Q61651011-6F283C95-6F6B-419F-8819-D8BBC7308F5F @default.
- Q61651011 P921 Q61651011-7DF9F1BD-92DD-4967-BA42-C757689D7082 @default.
- Q61651011 P356 030089160609200102 @default.
- Q61651011 P698 16683377 @default.
- Q61651011 P1433 Q15757838 @default.
- Q61651011 P1476 "Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study" @default.
- Q61651011 P2093 "Alberto Riccardi" @default.
- Q61651011 P2093 "Donatella Grasso" @default.
- Q61651011 P2093 "Giovanna Luchena" @default.
- Q61651011 P2093 "Giovanni Pansini" @default.
- Q61651011 P2093 "Giovanni Trotti" @default.
- Q61651011 P2093 "Marco Danova" @default.
- Q61651011 P2093 "Monica Giordano" @default.
- Q61651011 P2093 "Palma Pugliese" @default.
- Q61651011 P2093 "Raffaella Bertè" @default.
- Q61651011 P2093 "Silvia Brugnatelli" @default.
- Q61651011 P304 "6-12" @default.
- Q61651011 P31 Q13442814 @default.
- Q61651011 P356 "10.1177/030089160609200102" @default.
- Q61651011 P407 Q1860 @default.
- Q61651011 P433 "1" @default.
- Q61651011 P478 "92" @default.
- Q61651011 P50 Q37839539 @default.
- Q61651011 P577 "2006-01-01T00:00:00Z" @default.
- Q61651011 P698 "16683377" @default.
- Q61651011 P921 Q12859063 @default.
- Q61651011 P921 Q420436 @default.